跳至主要内容
临床试验/NCT07363551
NCT07363551招募中不适用

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月9日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
clinical symptoms

研究概览

简要总结

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

详细描述

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder. Outcome measures including clinical symptoms, inflammation biomarkers and gut microbiota profiles.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blind

入排标准

年龄范围
13 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Youth with a DSM-5 diagnosis of MDE

排除标准

  • Has a recent change in antidepressants or psychotherapy treatment within 4 weeks.
  • Allergic to omega-3 fatty acids

研究组 & 干预措施

omega-3

Active Comparator

EPA

干预措施: Omega-3 fatty acids (Combination Product)

placebo

Placebo Comparator

soy bean oil

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

clinical symptoms

时间窗: week 0,1,2,4,8,12

Hamilton Depression Rating Scale (HAMD)-21 item is a clinician-rated scale designed to assess the severity of depressive symptoms over the past week. It is commonly used in clinical trials and psychiatric practice Total Score Interpretation (Commonly Used) Total Score and Severity Level * 0-7: No depression / Normal * 8-13: Mild depression * 14-18: Moderate depression * 19-22: Severe depression -≥23: Very severe depression

次要结局

  • gut microbiota(week 0,12)
  • inflammatory cytokines (IL-6, hsCRP)(week 0,12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pei-Chen Chang

Consultant Psychiatrist

China Medical University Hospital

研究点 (1)

Loading locations...

相似试验